QR Code

Combination of targeted pharmacotherapy and immunotherapy with anti‐CD19 CAR NK cells in acute lymphoblastic leukemia

Abstract Anti‐CD19 CAR NK cells may provide a promising non‐HLA‐restricted immune cell product and have been clinically studied primarily on low‐grade B‐cell lymphoma patients. We used retroviral gene transfer to generate aCD19 CAR NK cells from the peripheral blood of healthy volunteers. We evaluat...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Hanna Kirchhoff, Caroline Schoenherr, Lisa Fleischer, Elizabeth K. Schweighart, Ruth Esser, Steven R. Talbot, Axel Schambach, Ulrike Koehl, Olaf Heidenreich, Matthias Eder, Michaela Scherr
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wiley 2025-10-01
Rangatū:HemaSphere
Urunga tuihono:https://doi.org/10.1002/hem3.70238
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite